Oral cytotoxic drugs.
Gridelli
Cesare
C
UO Oncologia Medica, AO San G Moscati, Avellino, Italy.
Rossi
Antonio
A
Guerriero
Ciro
C
Nicolella
Dario
D
Ferrara
Carmine
C
Del Gaizo
Filomena
F
Colantuoni
Giuseppe
G
Airoma
Giuseppe
G
Maione
Paolo
P
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D043823:Taxoids; D019772:Topotecan / Q000627:therapeutic use; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
D000970:Antineoplastic Agents; D001952:Bridged-Ring Compounds; D004791:Enzyme Inhibitors; D009944:Organoplatinum Compounds; D043823:Taxoids; C080625:taxane; D014747:Vinblastine; D019772:Topotecan; D000077235:Vinorelbine